Patient Controlled Epidural Analgesia Versus Local Infiltration Analgesia Following Knee Arthroplasty
Osteoarthritis

About this trial
This is an interventional treatment trial for Osteoarthritis focused on measuring local infiltration analgesia, Epidural, Enhanced Recovery, Total Knee Arthroplasty
Eligibility Criteria
Inclusion Criteria:
- All patients (age> 18years old) undergoing primary unilateral total knee arthroplasty (TKA) with a clinical diagnosis of osteoarthritis
Exclusion Criteria:
- Patients planned for uni-compartmental/bilateral or revision knee surgery patients
- Patients with a diagnosis of rheumatoid arthritis (RA)
- Patients with coagulation or anatomical defects e.g. preventing the use of spinal anaesthesia
- Known allergies to any medications within the trial
- Patients who were unable to give written informed consent
- Patients requiring pre-operative catheterisation for urinary outflow dysfunction
- Known neurological incident that would limit or make impossible early ambulation following surgery
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Active Comparator
Experimental
Patient Controlled Epidural (PCEA)
Local Infiltration Analgesia (LIA)
A lumbar epidural was sited using a side-directed technique towards the side of surgery following establishment of the spinal blockade. Following the completion of the operation, patients received 4ml of 0.25% levobupivacaine prior to leaving the operating room. Thereafter they were connected to a PCEA pump (McKinley 545) with no background infusion. Patients could self-medicate with a bolus 2ml of 0.125% bupivacaine via the PCEA system with a lockout time of 15 minutes to control their pain until the following morning (post-operative day one) when it was stopped. Nurse-administered rescue top-ups of 4ml of 0.25% levobupivacaine were available for insufficient analgesia. The epidural catheter was removed on the morning of post-operative day two (POD2).
Subcutaneous infiltration during surgery using 200ml of 0.2% plain ropivacaine. 50ml injected following bone preparation prior to implant cementation perpendicular to the posterior femur through the posterior joint capsule in 10ml aliquots. 30ml proximal to the suprapatellar pouch down to the femur.100ml spread into subcutaneous tissues including; collateral and cruciate ligaments, fatty and connective tissue on the anterior aspect of the incision. A 16 gauge epidural catheter inserted via a medial portal, 20ml was injected via the catheter following closure of wound. Post-operatively, patients received boluses of 40ml ropivacaine 0.2% via the catheter using a mechanical McKinley 595 pump 4 hours after leaving theatre, at 22:00 and 08:00 on post-operative day one.